Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,113 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00706498 | Phase II Study of BI 2536 in Prostate Cancer | completed | Phase 2 | 20 | Boehringer IngelheimINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT01581060 | Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | terminated | Phase 1 / Phase 2 | 41 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT00841191 |
| A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors |
| completed |
| Phase 1 / Phase 2 |
| 84 |
| Centocor, Inc.INDUSTRY |
| 5 |
| May 14, 2014 |
| clinicaltrials |
| NCT00474383 | An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | completed | Phase 2 | 47 | Cougar Biotechnology, Inc.INDUSTRY | 2 | May 12, 2014 | clinicaltrials |
| NCT01124786 | A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) | completed | Phase 2 | 367 | Clovis Oncology, Inc.INDUSTRY | 15 | Apr 17, 2014 | clinicaltrials |
| NCT00473512 | A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy | completed | Phase 1 / Phase 2 | 54 | Cougar Biotechnology, Inc.INDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01352208 | Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients | terminated | Phase 1 / Phase 2 | 13 | Astellas Pharma IncINDUSTRY | 3 | Mar 24, 2014 | clinicaltrials |
| NCT01843829 | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer(NeoSCOPE) | unknown | Phase 2 | 85 | Lisette NixonOTHER_GOV | 1 | Mar 24, 2014 | clinicaltrials |
| NCT00328198 | Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia | completed | Phase 2 | 86 | Genzyme, a Sanofi CompanyINDUSTRY | 6 | Mar 13, 2014 | clinicaltrials |
| NCT01125085 | 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors | completed | Phase 2 | 32 | Philogen S.p.A.INDUSTRY | 2 | Feb 25, 2014 | clinicaltrials |
| NCT00463788 | Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer(BALI-1) | completed | Phase 2 | 181 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 11 | Feb 13, 2014 | clinicaltrials |
| NCT00930098 | A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia | completed | Phase 2 | 74 | Genzyme, a Sanofi CompanyINDUSTRY | 6 | Feb 11, 2014 | clinicaltrials |
| NCT00410163 | Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients(BIFROST) | completed | Phase 2 | 61 | GlaxoSmithKlineINDUSTRY | 2 | Feb 10, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00394836 | HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab | completed | Phase 2 | 116 | GlaxoSmithKlineINDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00727831 | Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | completed | Phase 1 / Phase 2 | 4 | University College, LondonOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00354276 | VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia | unknown | Phase 2 | 85 | Vion PharmaceuticalsINDUSTRY | 3 | Jan 10, 2014 | clinicaltrials |
| NCT01096732 | Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)(HIPPoS) | terminated | Phase 2 | 3 | Lisa BaxOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00875433 | Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours | completed | Phase 2 | 60 | Boehringer IngelheimINDUSTRY | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00984334 | Naloxone SR Capsules in Patients With Opioid Induced Constipation | completed | Phase 2 | 40 | S.L.A. Pharma AGINDUSTRY | 2 | Dec 27, 2013 | clinicaltrials |
| NCT00003165 | Doxorubicin in Treating Women With Advanced Breast Cancer | unknown | Phase 2 | 25 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004077 | Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | completed | Phase 2 | 25 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00040690 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | completed | Phase 2 | 120 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00253591 | Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 500 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00334997 | Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis | completed | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00975897 | Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | completed | Phase 2 / Phase 3 | 3,240 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00053092 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma | completed | Phase 2 | 82 | Institute of Cancer Research, United KingdomOTHER | 2 | Dec 18, 2013 | clinicaltrials |
| NCT00077090 | Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer | unknown | Phase 2 | 63 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01310816 | A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma | completed | Phase 2 | 105 | Infinity Pharmaceuticals, Inc.INDUSTRY | 13 | Dec 5, 2013 | clinicaltrials |
| NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | completed | Phase 2 | 45 | Medical Research CouncilOTHER_GOV | 8 | Dec 4, 2013 | clinicaltrials |
| NCT00025441 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | completed | Phase 2 | — | Societe Internationale d'Oncologie PediatriqueOTHER | 3 | Dec 4, 2013 | clinicaltrials |
| NCT00464893 | Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | completed | Phase 2 | 70 | Neovii BiotechINDUSTRY | 4 | Dec 4, 2013 | clinicaltrials |
| NCT00389441 | Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer | completed | Phase 2 | 52 | PfizerINDUSTRY | 9 | Nov 25, 2013 | clinicaltrials |
| NCT00600821 | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. | completed | Phase 2 | 118 | PfizerINDUSTRY | 6 | Nov 8, 2013 | clinicaltrials |
| NCT00004237 | Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005821 | Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer | unknown | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00022204 | Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00036998 | Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer | unknown | Phase 2 | — | ImunonINDUSTRY | 2 | Nov 6, 2013 | clinicaltrials |
| NCT00041223 | IH636 Grape Seed Extract in Treating Hardening of Breast Tissue in Women Who Have Undergone Radiation Therapy for Early Breast Cancer | unknown | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00320190 | Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib | terminated | Phase 2 | 52 | Bristol-Myers SquibbINDUSTRY | 11 | Oct 30, 2013 | clinicaltrials |
| NCT00066378 | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 2 | 71 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Oct 24, 2013 | clinicaltrials |
| NCT00044551 | Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 29 | BayerINDUSTRY | 6 | Oct 14, 2013 | clinicaltrials |
| NCT01086254 | SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | completed | Phase 2 | 119 | SanofiINDUSTRY | 5 | Sep 24, 2013 | clinicaltrials |
| NCT00003733 | Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer | unknown | Phase 2 | 40 | SmithKline BeechamINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00005038 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00005054 | Temozolomide in Treating Women With Advanced Breast Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00022009 | Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 30 | Lymphoma Trials OfficeOTHER | 1 | Sep 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials